This HTML5 document contains 160 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1038/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37287465
rdf:type
wikibase:Item
schema:description
bilimsel makale 2009年の論文 artículu científicu espublizáu en 2009 wissenschaftlicher Artikel научная статья мақолаи илмӣ vědecký článek artikulong pang-agham 2009年學術文章 vedecký článok บทความทางวิทยาศาสตร์ سائنسی مضمون գիտական հոդված 2009年学术文章 наукова стаття, опублікована в червні 2009 2009年学术文章 artigo científico (publicado na 2009) articolo scientifico 2009 nî lūn-bûn مقالة علمية نشرت في 30 يونيو 2009 tieteellinen artikkeli article scientific article científic 2009年學術文章 2009年学术文章 2009年學術文章 teaduslik artikkel artículo científico publicado en 2009 мақолаи илмӣ article scientifique publié en 2009 artigo científico научни чланак vitskapeleg artikkel 2009년 논문 επιστημονικό άρθρο bài báo khoa học სამეცნიერო სტატია scienca artikolo научна статия mokslinis straipsnis 2009年學術文章 artykuł naukowy artikull shkencor naučni članak artigo científico (publicado na 2009) ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ videnskabelig artikel (udgivet 2009) מאמר מדעי 2009年學術文章 مقالهٔ علمی 2009年學術文章 2009年学术文章 wetenschappelijk artikel научни чланак 2009年学术文章 scientific article published on 30 June 2009 tudományos cikk vitenskapelig artikkel vetenskaplig artikel articol științific
p:P577
wds:Q37287465-7AB18F83-A748-40CE-8182-390EF0C1AE56 wds:Q37287465-5EF0B58D-BF61-4D8E-803A-2BD0E0AFFBB6
wdt:P577
2009-06-30T00:00:00Z 2009-07-21T00:00:00Z
p:P407
wds:Q37287465-5E1D13B9-8AA4-4E56-879E-176D4F762A16
wdt:P407
wd:Q1860
p:P2888
wds:Q37287465-E474F944-5126-41A0-B5AB-84C0189E4221
wdt:P2888
n12:sj.bjc.6605167
p:P2860
wds:Q37287465-696052AC-F16E-4481-BE67-BB1D8C732047 wds:Q37287465-81A7C61F-3E78-43D7-ABC0-0A78A3812BC9 wds:Q37287465-359F3E46-6BA7-404E-8247-E46ECD7C7B51 wds:Q37287465-B4921DCA-5452-4507-9DD5-38239B709EA7 wds:Q37287465-C0D38436-63FC-42C0-B242-2DCEB8E86BEB wds:Q37287465-DA28F956-25C8-48A2-B68D-C88D03F06AD6 wds:Q37287465-DF158AC4-87C0-40B7-8B42-2B4F265C7067 wds:Q37287465-9AB769CF-5C60-4EE0-B01B-BC0D951E8FA4 wds:Q37287465-9B84196A-BBC9-4ED6-965B-453CD3A6BE67 wds:Q37287465-EBCED6BF-8CB8-47E7-B31E-85E4E4D0B3C1 wds:Q37287465-FA81540F-9A10-4FA6-B8AD-E92142FA8B01
wdt:P2860
wd:Q33403399 wd:Q47626233 wd:Q33267032 wd:Q28282757 wd:Q24246777 wd:Q34583699 wd:Q37117085 wd:Q37067792 wd:Q34586576 wd:Q34586436 wd:Q46923017
p:P2093
wds:Q37287465-AD5407E8-1C24-4B37-B2D4-A6B8007F289D wds:Q37287465-A7093A23-B20C-4AA2-A351-C30D0880A1D1 wds:Q37287465-A2017B3B-B468-4F75-A5AE-060A43B6A622 wds:Q37287465-60F347D0-70BB-4CB2-B6CE-575F4A52ECAE wds:Q37287465-4D4FEDCE-1B8D-463B-A0A0-F132B7A17C2E wds:Q37287465-399AEB06-FB23-4618-89FE-75D580446D97 wds:Q37287465-357AEC05-9227-4368-B73B-3910D25EFAD7 wds:Q37287465-2906A53C-2F91-4D2B-8700-3D39D9E674F0
wdt:P2093
K Stein Z Liu T Moxham J S Thompson Coon C Green M Hoyle G Rogers K Welch
rdfs:label
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness
skos:prefLabel
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness
schema:name
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness
p:P1476
wds:Q37287465-EEC9F71C-71B3-489D-889E-EA14A00C30F2
wdt:P1476
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness
p:P304
wds:Q37287465-92537EB8-7A8B-4C08-915F-42286DF3C898
wdt:P304
238-243
p:P31
wds:Q37287465-97943874-63FE-47FA-AFC0-A58A4856F32D wds:Q37287465-0aa33abd-4055-9df1-df6c-db6e062fc6b2 wds:Q37287465-35666452-446a-84b8-ddf9-b17305f62b01 wds:Q37287465-52F48499-042F-44E9-9274-E76950593B94
wdt:P31
wd:Q13442814 wd:Q1504425 wd:Q58901591 wd:Q7318358
p:P921
wds:Q37287465-345DA0B2-2247-410D-9213-32ED978926AC wds:Q37287465-23DA4E92-7036-4457-9BA9-F7AFC7C85DE8 wds:Q37287465-F5598E4F-6C71-4A1B-B5E7-392BF45CC899 wds:Q37287465-5AF515F9-C076-45BD-8060-62FA576E1C58 wds:Q37287465-A9A152E0-D2A5-4E7A-B990-1C987A3BF7EC wds:Q37287465-A329DD1E-DE27-4355-9886-5975F0069A8F wds:Q37287465-CBEDCE0B-318F-44E6-A4A0-787D50BE9D54
wdt:P921
wd:Q66764603 wd:Q21014462 wd:Q1164529 wd:Q13641482 wd:Q413299 wd:Q1504425 wd:Q19000948
p:P698
wds:Q37287465-D0DA70C7-1787-4C51-A89B-77BE3D8E3D7B
wdtn:P698
n8:19568242
wdt:P698
19568242
p:P1433
wds:Q37287465-04028AF2-F7F4-4EEC-818D-A51650F039BC
wdt:P1433
wd:Q326309
p:P433
wds:Q37287465-84CB5A7A-1776-47FB-8D38-C91416EE9BD9
p:P478
wds:Q37287465-0BAA3F0E-4C1B-4F98-988A-21C99CA57148
wdt:P433
2
wdt:P478
101
p:P356
wds:Q37287465-53AA4C13-5827-4619-BD2A-66F949931FC0
wdtn:P356
n11:SJ.BJC.6605167
wdt:P356
10.1038/SJ.BJC.6605167
p:P5875
wds:Q37287465-4444A18E-E747-4C39-BA7D-41944EF478D0
wdt:P5875
26332094
p:P6179
wds:Q37287465-ABEDC0EA-0B87-4A77-B062-ADC55FFC3476
wdt:P6179
1013222336
p:P932
wds:Q37287465-CE59A784-DE76-4760-900B-D593CFCE6034
wdt:P932
2720220